| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Marker Therapeutics, Inc. | Vice President, Clinical Ops. | Employee Stock Option (right to buy) | 40,000 | 17 Feb 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MRKR | Marker Therapeutics, Inc. | 17 Feb 2022 | 1 | $0 | 4 | Vice President, Clinical Ops. | 22 Feb 2022, 16:02 |